ARIA Associated with Aducanumab
Episode 13 min 26s

ARIA Associated with Aducanumab

Dr. Jeff Burns talks with Dr. Lon Schneider about the development of ARIA in the Phase 3 EMERGE and ENGAGE trials that led to the FDA's accelerated approval of aducanumab for the treatment of Alzheimer disease.

You May Also Like

Community discussion